Safety · source year
2 selected, source-linked safety and enforcement records dated 2022. This is selective source coverage, not a complete timeline.
2 selected records.
2 connected profiles.
2 distinct public records.
Cited chronology
Octreotide
FDA's dated enforcement report D-0058-2023 lists Class I and source status Terminated for Viatris Inc. PeptideScanner connects the report to reviewed application ANDA079198 through exact openFDA application-number annotations.
Dulaglutide
FDA's dated enforcement report D-0884-2022 lists Class II and source status Completed for Cardinal Health Inc. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.